We describe a 6-year-old female patient who developed carbamazepine-associated toxic epidermal necrolysis.With active wound care,systemic methylprednisolone and intravenous immunoglobulin pulse therapies and multidisc...We describe a 6-year-old female patient who developed carbamazepine-associated toxic epidermal necrolysis.With active wound care,systemic methylprednisolone and intravenous immunoglobulin pulse therapies and multidisciplinary supportive care,the patient improved significantly.This case indicates that improving the management of Stevens-Johnson syndrome/Toxic epidermal necrolysis patients requires attention not only to the process of wound management but also to individual supportive care and active therapeutic intervention.Only through this can standardized care,including muco-cutaneous and visceral wound care,be delivered to provide high-quality care with improved clinical prognosis and quality of life.展开更多
基金National Natural Science Foundation of China(Grant no.81602754)%Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding(code:ZYLX201601)%Project of Excellent Talents in Beijing City(code:2013A003034000013)
文摘We describe a 6-year-old female patient who developed carbamazepine-associated toxic epidermal necrolysis.With active wound care,systemic methylprednisolone and intravenous immunoglobulin pulse therapies and multidisciplinary supportive care,the patient improved significantly.This case indicates that improving the management of Stevens-Johnson syndrome/Toxic epidermal necrolysis patients requires attention not only to the process of wound management but also to individual supportive care and active therapeutic intervention.Only through this can standardized care,including muco-cutaneous and visceral wound care,be delivered to provide high-quality care with improved clinical prognosis and quality of life.